Cash Flow Nephrocare Healt Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
97.00
87.00
33.00
-8.00
-27.00
0.00
Adjustment
168.00
93.00
80.00
68.00
64.00
44.00
Changes In working Capital
-5.00
-44.00
-33.00
-53.00
-18.00
-27.00
Cash Flow after changes in Working Capital
260.00
136.00
80.00
6.00
19.00
18.00
Cash Flow from Operating Activities
232.00
135.00
72.00
11.00
14.00
31.00
Cash Flow from Investing Activities
-391.00
-125.00
-51.00
-75.00
-129.00
-62.00
Cash Flow from Financing Activities
157.00
54.00
26.00
59.00
121.00
35.00
Net Cash Inflow / Outflow
-1.00
64.00
47.00
-4.00
6.00
5.00
Opening Cash & Cash Equivalents
125.00
61.00
14.00
18.00
12.00
7.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
123.00
125.00
61.00
14.00
18.00
12.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Nephrocare Healt
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
97.47
-276.34
373.00
135.27%
Adjustment
168.22
-5.98
173.00
2913.04%
Changes In working Capital
-5.64
-18.33
13.00
69.23%
Cash Flow after changes in Working Capital
260.06
-300.66
560.00
186.50%
Cash Flow from Operating Activities
232.58
-299.9
531.00
177.55%
Cash Flow from Investing Activities
-391.62
-462.11
71.00
15.25%
Cash Flow from Financing Activities
157.11
756.78
-599.00
-79.24%
Net Cash Inflow / Outflow
-1.93
-5.23
4.00
63.10%
Opening Cash & Cash Equivalents
125.82
15.03
110.00
737.13%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
123.89
9.8
114.00
1164.18%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 71.84% vs 87.26% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
232.58
135.35
71.84%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
